$ATOM
Atomera Inc

2023 Q3 Form 10-Q Financial Statement

#000168316823005213 Filed on August 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00
YoY Change -100.0%
Gross Profit Margin
Selling, General & Admin $2.048M $2.168M
YoY Change 7.0% 7.65%
% of Gross Profit
Research & Development $3.305M $3.192M
YoY Change 20.49% 31.2%
% of Gross Profit
Depreciation & Amortization $310.0K $310.0K
YoY Change 1531.58% 1531.58%
% of Gross Profit
Operating Expenses $5.353M $5.360M
YoY Change 14.95% 20.53%
Operating Profit -$5.353M -$5.360M
YoY Change 14.99% 20.53%
Interest Expense $47.00K $101.0K
YoY Change -21.67% 46.38%
% of Operating Profit
Other Income/Expense, Net $314.0K $107.0K
YoY Change 492.45% -414.71%
Pretax Income -$5.040M -$5.152M
YoY Change 9.52% 14.97%
Income Tax
% Of Pretax Income
Net Earnings -$5.039M -$5.152M
YoY Change 9.5% 14.97%
Net Earnings / Revenue
Basic Earnings Per Share -$0.20 -$0.21
Diluted Earnings Per Share -$0.20 -$0.21
COMMON SHARES
Basic Shares Outstanding 25.79M shares 24.41M shares
Diluted Shares Outstanding 25.26M shares 24.68M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.39M $23.84M
YoY Change -12.44% 9.14%
Cash & Equivalents $12.64M $12.90M
Short-Term Investments $7.750M $10.93M
Other Short-Term Assets $390.0K $650.0K
YoY Change -34.67% 0.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $20.84M $24.54M
YoY Change -12.76% 9.1%
LONG-TERM ASSETS
Property, Plant & Equipment $129.0K $4.349M
YoY Change -21.34% 2371.02%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $110.0K $105.0K
YoY Change 4.76% 0.0%
Total Long-Term Assets $3.992M $4.454M
YoY Change -27.09% -29.23%
TOTAL ASSETS
Total Short-Term Assets $20.84M $24.54M
Total Long-Term Assets $3.992M $4.454M
Total Assets $24.83M $28.99M
YoY Change -15.43% 0.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $462.0K $562.0K
YoY Change -11.83% 29.49%
Accrued Expenses $230.0K $1.055M
YoY Change 12.2% 395.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.300M $1.357M
YoY Change 24.64% -2.72%
Total Short-Term Liabilities $2.951M $2.974M
YoY Change 4.94% 6.4%
LONG-TERM LIABILITIES
Long-Term Debt $2.070M $2.376M
YoY Change -36.39% -33.61%
Other Long-Term Liabilities $350.0K $400.0K
YoY Change -43.0% -39.21%
Total Long-Term Liabilities $2.420M $2.776M
YoY Change -37.44% -34.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.951M $2.974M
Total Long-Term Liabilities $2.420M $2.776M
Total Liabilities $5.365M $5.750M
YoY Change -19.69% -18.23%
SHAREHOLDERS EQUITY
Retained Earnings -$198.5M -$193.5M
YoY Change 10.88% 10.92%
Common Stock $218.0M $216.7M
YoY Change 8.07% 10.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $19.46M $23.24M
YoY Change
Total Liabilities & Shareholders Equity $24.83M $28.99M
YoY Change -15.43% 0.72%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$5.039M -$5.152M
YoY Change 9.5% 14.97%
Depreciation, Depletion And Amortization $310.0K $310.0K
YoY Change 1531.58% 1531.58%
Cash From Operating Activities -$3.480M -$3.938M
YoY Change 17.33% 57.27%
INVESTING ACTIVITIES
Capital Expenditures $10.00K $3.000K
YoY Change -242.86% -200.0%
Acquisitions
YoY Change
Other Investing Activities $3.250M -$5.911M
YoY Change
Cash From Investing Activities $3.240M -$5.914M
YoY Change -46385.71% 197033.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -30.00K 10.64M
YoY Change -100.68% -10135.85%
NET CHANGE
Cash From Operating Activities -3.480M -3.938M
Cash From Investing Activities 3.240M -5.914M
Cash From Financing Activities -30.00K 10.64M
Net Change In Cash -270.0K 786.0K
YoY Change -118.63% -130.08%
FREE CASH FLOW
Cash From Operating Activities -$3.480M -$3.938M
Capital Expenditures $10.00K $3.000K
Free Cash Flow -$3.490M -$3.941M
YoY Change 17.95% 57.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001420520
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37850
dei Entity Registrant Name
EntityRegistrantName
ATOMERA INCORPORATED
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
30-0509586
dei Entity Address Address Line1
EntityAddressAddressLine1
750 University Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 280
dei Entity Address City Or Town
EntityAddressCityOrTown
Los Gatos
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95032
dei City Area Code
CityAreaCode
(408)
dei Local Phone Number
LocalPhoneNumber
442-5248
dei Security12b Title
Security12bTitle
Common stock: Par value $0.001
dei Trading Symbol
TradingSymbol
ATOM
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25793907 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12904000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21184000 usd
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
10931000 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
0 usd
CY2023Q2 us-gaap Interest Receivable Current
InterestReceivableCurrent
50000 usd
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
0 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
650000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
418000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
24535000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
21602000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
135000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
158000 usd
CY2023Q2 ATOM Longterm Prepaid Maintenance And Supplies
LongtermPrepaidMaintenanceAndSupplies
91000 usd
CY2022Q4 ATOM Longterm Prepaid Maintenance And Supplies
LongtermPrepaidMaintenanceAndSupplies
91000 usd
CY2023Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
14000 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
14000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
631000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
700000 usd
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
3583000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
4164000 usd
CY2023Q2 us-gaap Assets
Assets
28989000 usd
CY2022Q4 us-gaap Assets
Assets
26729000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
562000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
397000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
218000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
173000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
578000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
967000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
259000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
245000 usd
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1357000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1126000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2974000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2908000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
400000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
521000 usd
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2376000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2986000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
5750000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
6415000 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2500000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2500000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
47500000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
47500000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25770000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25770000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23973000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23973000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
26000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
24000 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
216681000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
203585000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-193466000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-183295000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
23239000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
20314000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28989000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26729000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
375000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
-0 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
-0 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
-0 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
81000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
0 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
294000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3192000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2433000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6228000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4772000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1775000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1667000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3517000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3315000 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
393000 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
347000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
782000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
672000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
5360000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
4447000 usd
us-gaap Operating Expenses
OperatingExpenses
10527000 usd
us-gaap Operating Expenses
OperatingExpenses
8759000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5360000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4447000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-10527000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-8465000 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
152000 usd
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
35000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
351000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
38000 usd
CY2023Q2 ATOM Accretion Income
AccretionIncome
107000 usd
CY2022Q2 ATOM Accretion Income
AccretionIncome
0 usd
ATOM Accretion Income
AccretionIncome
109000 usd
ATOM Accretion Income
AccretionIncome
0 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
51000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
69000 usd
us-gaap Interest Expense
InterestExpense
104000 usd
us-gaap Interest Expense
InterestExpense
140000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
208000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-34000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
356000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-102000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-5152000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-4481000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10171000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8567000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.37
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24677000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22936000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24171000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22894000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24677000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22936000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24171000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22894000 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-5152000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-4481000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10171000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8567000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
0 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
0 usd
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-2000 usd
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
0 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5152000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4481000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10173000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8567000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
20314000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
927000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
39000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
274000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5019000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-2000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
16533000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1030000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
39000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10789000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-5152000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
23239000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
28381000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
726000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
166000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4086000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
25187000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
859000 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
185000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-4481000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
21750000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10171000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8567000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
40000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
39000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
102000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
99000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
581000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
638000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1957000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1585000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-89000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
42000 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-0 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
232000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
341000 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
165000 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
96000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
45000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
10000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-389000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-91000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-139000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-83000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8172000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6615000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19000 usd
ATOM Purchase Of Availableforsale Securities
PurchaseOfAvailableforsaleSecurities
10853000 usd
ATOM Purchase Of Availableforsale Securities
PurchaseOfAvailableforsaleSecurities
-0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10871000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19000 usd
ATOM Proceeds From At The Market Sale Of Stock
ProceedsFromAtTheMarketSaleOfStock
11063000 usd
ATOM Proceeds From At The Market Sale Of Stock
ProceedsFromAtTheMarketSaleOfStock
185000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
78000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
166000 usd
ATOM Payments On Principal Of Financing Lease
PaymentsOnPrincipalOfFinancingLease
378000 usd
ATOM Payments On Principal Of Financing Lease
PaymentsOnPrincipalOfFinancingLease
578000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10763000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-227000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-8280000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6861000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21184000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28699000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12904000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21838000 usd
us-gaap Interest Paid Net
InterestPaidNet
104000 usd
us-gaap Interest Paid Net
InterestPaidNet
140000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_801_eus-gaap--NatureOfOperations_zHAffAo2oDV8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_825_z6A0ErcwGHUl">NATURE OF OPERATIONS</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Atomera Incorporated (“Atomera” or the “Company”) was incorporated in the state of Delaware in March 2007 under the name MEARS Technologies, Inc. and is engaged in the development, commercialization and licensing of proprietary processes and technologies for the semiconductor industry. On January 12, 2016, the Company changed its name to Atomera Incorporated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Atomera is an early-stage company, having only recently begun limited revenue-generating activities, and is devoting substantially all its efforts toward technology research and development and to commercially licensing its technology to designers and manufacturers of integrated circuits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2023Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
23800000 usd
CY2023Q2 ATOM Working Capital
WorkingCapital
21600000 usd
CY2023Q2 us-gaap Interest Receivable
InterestReceivable
50000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
375000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
375000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3919000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3464000 shares
us-gaap Lessee Finance Lease Variable Lease Payment Terms And Conditions
LesseeFinanceLeaseVariableLeasePaymentTermsAndConditions
Effective August 1, 2022, the lease payments for this tool were reduced to $100,824 per month for the period August 1, 2022 through July 31, 2023. This adjustment to the variable lease payments resulted in a reduction in ROU and corresponding lease liability
us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
Effective May 1, 2023, the Company leased an additional 404 square feet at its Tempe office location under an amendment to its current lease. The monthly rent payment increased from $1,277 per month to $2,365 per month and the increased rent under the amended lease is accounted for as a modification to the lease under ASC 842 at the time of commencement.
us-gaap Lessee Operating Lease Option To Terminate
LesseeOperatingLeaseOptionToTerminate
The Company terminated its office lease in Cambridge, Massachusetts as of March 31, 2023. The cost of the lease was $2,942 per month.
CY2023Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
290000 usd
CY2022Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
319000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
581000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
638000 usd
CY2023Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
51000 usd
CY2022Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
69000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
104000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
140000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
341000 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
388000 usd
us-gaap Lease Cost
LeaseCost
685000 usd
us-gaap Lease Cost
LeaseCost
778000 usd
CY2023Q2 ATOM Fixed Lease Costs
FixedLeaseCosts
64000 usd
CY2022Q2 ATOM Fixed Lease Costs
FixedLeaseCosts
62000 usd
ATOM Fixed Lease Costs
FixedLeaseCosts
126000 usd
ATOM Fixed Lease Costs
FixedLeaseCosts
124000 usd
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
244000 usd
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
9000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
541000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
20000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
308000 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
71000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
667000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
144000 usd
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
55000 usd
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
54000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
111000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
108000 usd
CY2023Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
241000 usd
CY2022Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
359000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
482000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
718000 usd
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
33000 usd
CY2022Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
33000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0548 pure
CY2023Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0525 pure
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M6D
CY2023Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y1M6D
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1030000 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
859000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1957000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1585000 usd

Files In Submission

Name View Source Status
0001683168-23-005213-index-headers.html Edgar Link pending
0001683168-23-005213-index.html Edgar Link pending
0001683168-23-005213.txt Edgar Link pending
0001683168-23-005213-xbrl.zip Edgar Link pending
atom-20230630.xsd Edgar Link pending
atomera_ex3101.htm Edgar Link pending
atomera_ex3102.htm Edgar Link pending
atomera_ex3201.htm Edgar Link pending
atomera_i10q-063023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
atom-20230630_cal.xml Edgar Link unprocessable
atom-20230630_def.xml Edgar Link unprocessable
atom-20230630_lab.xml Edgar Link unprocessable
atom-20230630_pre.xml Edgar Link unprocessable
atomera_i10q-063023_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable